{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:16:45Z","timestamp":1790345805105,"version":"4.1.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T00:00:00Z","timestamp":1659571200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["JPR-2017-034\/2-1"],"award-info":[{"award-number":["JPR-2017-034\/2-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011748","name":"Phospholipid Research Center","doi-asserted-by":"publisher","award":["JPR-2015-034\/1-1"],"award-info":[{"award-number":["JPR-2015-034\/1-1"]}],"id":[{"id":"10.13039\/501100011748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alternatively-activated, M2-like tumor-associated macrophages (TAM) strongly contribute to tumor growth, invasiveness and metastasis. Technologies to disable the pro-tumorigenic function of these TAMs are of high interest to immunotherapy research. Here we show that by designing engineered nanoliposomes bio-mimicking peroxidated phospholipids that are recognised and internalised by scavenger receptors, TAMs can be targeted. Incorporation of phospholipids possessing a terminal carboxylate group at the <jats:italic>sn-2<\/jats:italic> position into nanoliposome bilayers drives their uptake by M2 macrophages with high specificity. Molecular dynamics simulation of the lipid bilayer predicts flipping of the <jats:italic>sn-2<\/jats:italic> tail towards the aqueous phase, while molecular docking data indicates interaction of the tail with Scavenger Receptor Class B type 1 (SR-B1). In vivo, the engineered nanoliposomes are distributed specifically to M2-like macrophages and, upon delivery of the STAT6 inhibitor (AS1517499), zoledronic acid or muramyl tripeptide, these cells promote reduction of the premetastatic niche and\/or tumor growth. Altogether, we demonstrate the efficiency and versatility of our engineered \u201ctail-flipping\u201d nanoliposomes in a pre-clinical model, which paves the way to their development as cancer immunotherapeutics in humans.<\/jats:p>","DOI":"10.1038\/s41467-022-32091-9","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T20:14:04Z","timestamp":1659644044000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Cancer immune therapy using engineered \u201btail-flipping\u2019 nanoliposomes targeting alternatively activated macrophages"],"prefix":"10.1038","volume":"13","author":[{"given":"Praneeth R.","family":"Kuninty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Binnemars-Postma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8670-6087","authenticated-orcid":false,"given":"Ahmed","family":"Jarray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunal P.","family":"Pednekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1392-5697","authenticated-orcid":false,"given":"Marcel A.","family":"Heinrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6944-8848","authenticated-orcid":false,"given":"Helen J.","family":"Pijffers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hetty","family":"ten Hoopen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"Storm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Hoogevest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5645-527X","authenticated-orcid":false,"given":"Wouter K.","family":"den Otter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1050-650X","authenticated-orcid":false,"given":"Jai","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,4]]},"reference":[{"key":"32091_CR1","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies, M. et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat. Med. 24, 541\u2013550 (2018).","journal-title":"Nat. Med."},{"key":"32091_CR2","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1016\/j.cell.2017.01.016","volume":"168","author":"WA Lim","year":"2017","unstructured":"Lim, W. A. & June, C. H. The principles of engineering immune cells to treat cancer. Cell 168, 724\u2013740 (2017).","journal-title":"Cell"},{"key":"32091_CR3","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.cell.2020.03.001","volume":"181","author":"EW Weber","year":"2020","unstructured":"Weber, E. W., Maus, M. V. & Mackall, C. L. The emerging landscape of immune cell therapies. Cell 181, 46\u201362 (2020).","journal-title":"Cell"},{"key":"32091_CR4","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","volume":"20","author":"MG Netea","year":"2020","unstructured":"Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375\u2013388 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"32091_CR5","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41573-019-0025-4","volume":"18","author":"WJM Mulder","year":"2019","unstructured":"Mulder, W. J. M., Ochando, J., Joosten, L. A. B., Fayad, Z. A. & Netea, M. G. Therapeutic targeting of trained immunity. Nat. Rev. Drug Discov. 18, 553\u2013566 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"32091_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nature21349","volume":"541","author":"DS Chen","year":"2017","unstructured":"Chen, D. S. & Mellman, I. Elements of cancer immunity and the cancer-immune set point. Nature 541, 321\u2013330 (2017).","journal-title":"Nature"},{"key":"32091_CR7","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674 (2011).","journal-title":"Cell"},{"key":"32091_CR8","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","volume":"14","author":"A Mantovani","year":"2017","unstructured":"Mantovani, A., Marchesi, F., Malesci, A., Laghi, L. & Allavena, P. Tumour-associated macrophages as treatment targets in oncology. Nat. Rev. Clin. Oncol. 14, 399\u2013416 (2017).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"32091_CR9","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-018-0010-y","volume":"18","author":"B Lim","year":"2018","unstructured":"Lim, B., Woodward, W. A., Wang, X., Reuben, J. M. & Ueno, N. T. Inflammatory breast cancer biology: the tumour microenvironment is key. Nat. Rev. Cancer 18, 485\u2013499 (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"32091_CR10","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/s41577-019-0127-6","volume":"19","author":"DG DeNardo","year":"2019","unstructured":"DeNardo, D. G. & Ruffell, B. Macrophages as regulators of tumour immunity and immunotherapy. Nat. Rev. Immunol. 19, 369\u2013382 (2019).","journal-title":"Nat. Rev. Immunol."},{"key":"32091_CR11","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","volume":"17","author":"L Cassetta","year":"2018","unstructured":"Cassetta, L. & Pollard, J. W. Targeting macrophages: therapeutic approaches in cancer. Nat. Rev. Drug Discov. 17, 887\u2013904 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"32091_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41577-019-0260-2","volume":"20","author":"PJ Murray","year":"2020","unstructured":"Murray, P. J. On macrophage diversity and inflammatory metabolic timers. Nat. Rev. Immunol. 20, 89\u201390 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"32091_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/path.5403","volume":"250","author":"T Beltraminelli","year":"2020","unstructured":"Beltraminelli, T. & De Palma, M. Biology and therapeutic targeting of tumour-associated macrophages. J. Pathol. 250, 573\u2013592 (2020).","journal-title":"J. Pathol."},{"key":"32091_CR14","doi-asserted-by":"publisher","first-page":"32005","DOI":"10.1073\/pnas.2015343117","volume":"117","author":"S Eisinger","year":"2020","unstructured":"Eisinger, S. et al. Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells. Proc. Natl Acad. Sci. USA 117, 32005\u201332016 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"32091_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fonc.2018.00049","volume":"8","author":"AR Poh","year":"2018","unstructured":"Poh, A. R. & Ernst, M. Targeting macrophages in cancer: from bench to bedside. Front. Oncol. 8, 49 (2018).","journal-title":"Front. Oncol."},{"key":"32091_CR16","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.trecan.2018.03.011","volume":"4","author":"GR Doak","year":"2018","unstructured":"Doak, G. R., Schwertfeger, K. L. & Wood, D. K. Distant relations: macrophage functions in the metastatic niche. Trends Cancer 4, 445\u2013459 (2018).","journal-title":"Trends Cancer"},{"key":"32091_CR17","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.trecan.2019.10.013","volume":"5","author":"T Keeley","year":"2019","unstructured":"Keeley, T., Costanzo-Garvey, D. L. & Cook, L. M. Unmasking the many faces of tumor-associated neutrophils and macrophages: considerations for targeting innate immune cells in cancer. Trends Cancer 5, 789\u2013798 (2019).","journal-title":"Trends Cancer"},{"key":"32091_CR18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.it.2019.02.003","volume":"40","author":"P Pathria","year":"2019","unstructured":"Pathria, P., Louis, T. L. & Varner, J. A. Targeting tumor-associated macrophages in cancer. Trends Immunol. 40, 310\u2013327 (2019).","journal-title":"Trends Immunol."},{"key":"32091_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.cell.2020.09.059","volume":"183","author":"B Priem","year":"2020","unstructured":"Priem, B. et al. Trained immunity-promoting nanobiologic therapy suppresses tumor growth and potentiates checkpoint inhibition. Cell 183, 786\u2013801 (2020).","journal-title":"Cell"},{"key":"32091_CR20","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck, S. M. et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression. Nat. Med. 19, 1264\u20131272 (2013).","journal-title":"Nat. Med."},{"key":"32091_CR21","doi-asserted-by":"publisher","first-page":"e101260","DOI":"10.1371\/journal.pone.0101260","volume":"9","author":"R Sabatino","year":"2014","unstructured":"Sabatino, R. et al. Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells. PLoS ONE 9, e101260 (2014).","journal-title":"PLoS ONE"},{"key":"32091_CR22","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1096\/fj.201700629R","volume":"32","author":"K Binnemars-Postma","year":"2018","unstructured":"Binnemars-Postma, K., Bansal, R., Storm, G. & Prakash, J. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer. FASEB J. 32, 969\u2013978 (2018).","journal-title":"FASEB J."},{"key":"32091_CR23","first-page":"30561","volume":"S1742-7061","author":"P Figueiredo","year":"2020","unstructured":"Figueiredo, P. et al. Peptide-guided resiquimod-loaded lignin nanoparticles convert tumor-associated macrophages from M2 to M1 phenotype for enhanced chemotherapy. Acta Biomater. S1742-7061, 30561\u201330564 (2020).","journal-title":"Acta Biomater."},{"key":"32091_CR24","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1021\/acs.nanolett.9b00021","volume":"19","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Reprogramming tumor immune microenvironment (TIME) and metabolism via biomimetic targeting codelivery of shikonin\/JQ1. Nano Lett. 19, 2935\u20132944 (2019).","journal-title":"Nano Lett."},{"key":"32091_CR25","first-page":"eaax6337","volume":"12","author":"JM Jaynes","year":"2020","unstructured":"Jaynes, J. M. et al. Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses. Sci. Tansl. Med. 12, eaax6337 (2020).","journal-title":"Sci. Tansl. Med."},{"key":"32091_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.tips.2020.08.003","volume":"41","author":"Y Yang","year":"2020","unstructured":"Yang, Y., Guo, J. & Huang, L. Tackling TAMs for cancer immunotherapy: it\u2019s nano time. Trends Pharmacol. Sci. 41, 701\u2013714 (2020).","journal-title":"Trends Pharmacol. Sci."},{"key":"32091_CR27","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.3389\/fimmu.2018.02904","volume":"9","author":"DA Patten","year":"2018","unstructured":"Patten, D. A. & Shetty, S. More than just a removal service: scavenger receptors in leukocyte trafficking. Front. Immunol. 9, 2904 (2018).","journal-title":"Front. Immunol."},{"key":"32091_CR28","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.2217\/nnm-2016-0233","volume":"11","author":"KA Binnemars-Postma","year":"2016","unstructured":"Binnemars-Postma, K. A., Ten Hoopen, H. W., Storm, G. & Prakash, J. Differential uptake of nanoparticles by human M1 and M2 polarized macrophages: protein corona as a critical determinant. Nanomedicine 11, 2889\u20132902 (2016).","journal-title":"Nanomedicine"},{"key":"32091_CR29","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.tem.2008.11.001","volume":"20","author":"X Su","year":"2009","unstructured":"Su, X. & Abumrad, N. A. Cellular fatty acid uptake: a pathway under construction. Trends Endocrinol. Metab. 20, 72\u201377 (2009).","journal-title":"Trends Endocrinol. Metab."},{"key":"32091_CR30","doi-asserted-by":"publisher","first-page":"44222","DOI":"10.1074\/jbc.M103942200","volume":"276","author":"K Ohtani","year":"2001","unstructured":"Ohtani, K. et al. The membrane-type collectin CL-P1 is a scavenger receptor on vascular endothelial cells. J. Biol. Chem. 276, 44222\u201344228 (2001).","journal-title":"J. Biol. Chem."},{"key":"32091_CR31","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-60327-029-8_24","volume":"610","author":"S Parthasarathy","year":"2010","unstructured":"Parthasarathy, S., Raghavamenon, A., Garelnabi, M. O. & Santanam, N. Oxidized low-density lipoprotein. Methods Mol. Biol. 610, 403\u2013417 (2010).","journal-title":"Methods Mol. Biol."},{"key":"32091_CR32","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1074\/jbc.M109.082800","volume":"285","author":"D Gao","year":"2010","unstructured":"Gao, D. et al. Structural basis for the recognition of oxidized phospholipids in oxidized low density lipoproteins by class B scavenger receptors CD36 and SR-BI. J. Biol. Chem. 285, 4447\u20134454 (2010).","journal-title":"J. Biol. Chem."},{"key":"32091_CR33","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica, A. & Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J. Clin. Investig. 122, 787\u2013795 (2012).","journal-title":"J. Clin. Investig."},{"key":"32091_CR34","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1074\/jbc.M707348200","volume":"283","author":"ME Greenberg","year":"2008","unstructured":"Greenberg, M. E. et al. The lipid whisker model of the structure of oxidized cell membranes. J. Biol. Chem. 283, 2385\u20132396 (2008).","journal-title":"J. Biol. Chem."},{"key":"32091_CR35","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res. 46, W296\u2013W303 (2018).","journal-title":"Nucleic Acids Res."},{"key":"32091_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02044-8","volume":"8","author":"KS Conrad","year":"2017","unstructured":"Conrad, K. S. et al. Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies. Nat. Commun. 8, 1908 (2017).","journal-title":"Nat. Commun."},{"key":"32091_CR37","doi-asserted-by":"publisher","first-page":"18452","DOI":"10.1074\/jbc.M111.229872","volume":"286","author":"L Gaidukov","year":"2011","unstructured":"Gaidukov, L., Nager, A. R., Xu, S., Penman, M. & Krieger, M. Glycine dimerization motif in the N-terminal transmembrane domain of the high density lipoprotein receptor SR-BI required for normal receptor oligomerization and lipid transport. J. Biol. Chem. 286, 18452\u201318464 (2011).","journal-title":"J. Biol. Chem."},{"key":"32091_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/JLB.3RU1018-378RR","volume":"106","author":"LX Wang","year":"2018","unstructured":"Wang, L. X., Zhang, S. X., Wu, H. J., Rong, X. L. & Guo, J. M2b macrophage polarization and its roles in diseases. J. Leukoc. Biol. 106, 345\u2013358 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"32091_CR39","first-page":"4966","volume":"46","author":"I Saiki","year":"1986","unstructured":"Saiki, I., Milas, L., Hunter, N. & Fidler, I. J. Treatment of experimental lung metastasis with local thoracic irradiation followed by systemic macrophage activation with liposomes containing muramyl tripeptide. Cancer Res. 46, 4966\u20134970 (1986).","journal-title":"Cancer Res."},{"key":"32091_CR40","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.nantod.2015.06.006","volume":"10","author":"HH Gustafson","year":"2015","unstructured":"Gustafson, H. H., Holt-Casper, D., Grainger, D. W. & Ghandehari, H. Nanoparticle uptake: the phagocyte problem. Nano Today 10, 487\u2013510 (2015).","journal-title":"Nano Today"},{"key":"32091_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/0005-2736(73)90408-2","volume":"298","author":"S Batzri","year":"1973","unstructured":"Batzri, S. & Korn, E. D. Single bilayer liposomes prepared without sonication. Biochim. Biophys. Acta 298, 1015\u20131019 (1973).","journal-title":"Biochim. Biophys. Acta"},{"key":"32091_CR42","first-page":"22","volume":"3","author":"FR Miller","year":"1983","unstructured":"Miller, F. R., Miller, B. E. & Heppner, G. H. Characterization of metastatic heterogeneity among subpopulations of a single mouse mammary tumor: heterogeneity in phenotypic stability. Invasion Metastasis 3, 22\u201331 (1983).","journal-title":"Invasion Metastasis"},{"key":"32091_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/jcph.1995.1039","volume":"117","author":"S Plimpton","year":"1995","unstructured":"Plimpton, S. Fast parallel algorithms for short-range molecular dynamics. J. Comput Phys. 117, 1\u201319 (1995).","journal-title":"J. Comput Phys."},{"key":"32091_CR44","doi-asserted-by":"publisher","first-page":"108171","DOI":"10.1016\/j.cpc.2021.108171","volume":"271","author":"AP Thompson","year":"2022","unstructured":"Thompson, A. P. et al. LAMMPS - a flexible simulation tool for particle-based materials modeling at the atomic, meso, and continuum scales. Comput. Phys. Commun. 271, 108171 (2022).","journal-title":"Comput. Phys. Commun."},{"key":"32091_CR45","doi-asserted-by":"publisher","first-page":"6874","DOI":"10.1021\/acs.jpcb.1c03559","volume":"125","author":"S Kim","year":"2021","unstructured":"Kim, S. & Voth, G. A. Physical characterization of triolein and implications for its role in lipid droplet biogenesis. J. Phys. Chem. B 125, 6874\u20136888 (2021).","journal-title":"J. Phys. Chem. B"},{"key":"32091_CR46","doi-asserted-by":"publisher","first-page":"4025","DOI":"10.1039\/C8NR09381D","volume":"11","author":"S Wang","year":"2019","unstructured":"Wang, S., Guo, H., Li, Y. & Li, X. Penetration of nanoparticles across a lipid bilayer: effects of particle stiffness and surface hydrophobicity. Nanoscale 11, 4025\u20134034 (2019).","journal-title":"Nanoscale"},{"key":"32091_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8219","volume":"6","author":"M Simunovic","year":"2015","unstructured":"Simunovic, M. & Voth, G. A. Membrane tension controls the assembly of curvature-generating proteins. Nat. Commun. 6, 7219 (2015).","journal-title":"Nat. Commun."},{"key":"32091_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07320-9","volume":"9","author":"W Lu","year":"2018","unstructured":"Lu, W., Schafer, N. P. & Wolynes, P. G. Energy landscape underlying spontaneous insertion and folding of an alpha-helical transmembrane protein into a bilayer. Nat. Commun. 9, 4949 (2018).","journal-title":"Nat. Commun."},{"key":"32091_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1021\/ma00149a018","volume":"18","author":"DN Theodorou","year":"1985","unstructured":"Theodorou, D. N. & Ulrich, W. S. Detailed molecular structure of a vinyl polymer glass. Macromolecules 18, 1467\u20131478 (1985).","journal-title":"Macromolecules"},{"key":"32091_CR50","unstructured":"Scienomics M. P., http:\/\/www.scienomics.com\/."},{"key":"32091_CR51","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1021\/ja00086a030","volume":"116","author":"H Sun","year":"1994","unstructured":"Sun, H., Mumby, S. J., Maple, J. R. & Hagler, A. T. An ab initio CFF93 all-atom force field for polycarbonates. J. Am. Chem. Soc. 116, 2978\u20132987 (1994).","journal-title":"J. Am. Chem. Soc."},{"key":"32091_CR52","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1063\/1.447334","volume":"81","author":"S Nos\u00e9","year":"1984","unstructured":"Nos\u00e9, S. A unified formulation of the constant temperature molecular dynamics methods. J. Chem. Phys. 81, 511\u2013519 (1984).","journal-title":"J. Chem. Phys."},{"key":"32091_CR53","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","volume":"31","author":"WG Hoover","year":"1985","unstructured":"Hoover, W. G. Canonical dynamics: equilibrium phase-space distributions. Phy Rev. A 31, 1695 (1985).","journal-title":"Phy Rev. A"},{"key":"32091_CR54","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJ Berendsen","year":"1984","unstructured":"Berendsen, H. J., Postma, J. V., van Gunsteren, W. F., DiNola, A. R. H. J. & Haak, J. R. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81, 3684\u20133690 (1984).","journal-title":"J. Chem. Phys."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32091-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32091-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32091-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T18:16:26Z","timestamp":1669313786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-32091-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,4]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["32091"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-32091-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,4]]},"assertion":[{"value":"1 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P., G.S., P.v.H. have filed a patent application (EP18162956.9). The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4548"}}